22 results on '"Ding, Zhenbin"'
Search Results
2. A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma
- Author
-
Jiang, Xifei, Deng, Wenjia, Tao, Siyao, Tang, Zheng, Chen, Yuehong, Tian, Mengxin, Wang, Ting, Tao, Chenyang, Li, Yize, Fang, Yuan, Pu, Congying, Gao, Jun, Wang, Xiaomin, Qu, Weifeng, Gai, Xiameng, Ding, Zhenbin, Fu, Yixian, Zheng, Ying, Cao, Siyuwei, Zhou, Jian, Huang, Min, Liu, Weiren, Xu, Jun, Fan, Jia, and Shi, Yinghong
- Published
- 2023
- Full Text
- View/download PDF
3. Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures
- Author
-
Ding, Zhenbin, Wu, Hong, Zeng, Yongyi, Kuang, Ming, Yang, Wei, Meng, Zhiqiang, Chen, Yajin, Hao, Chunyi, Zou, Shubing, Sun, Huichuan, Liu, Chang, Lin, Kecan, Shi, Guoming, Wang, Xiaoying, Fu, Xiutao, Chen, Rongxin, Chen, Yi, Liang, Ruifang, Kano, Takeshi, Pan, Huiyan, Yang, Suna, Fan, Jia, and Zhou, Jian
- Published
- 2023
- Full Text
- View/download PDF
4. Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma
- Author
-
Huang Run, Zhu Guiqi, Fu Xiutao, Liu Weiren, Tao Chenyang, Gao Jun, Qu Weifeng, Fang Yuan, Jiang Xifei, Ding Zhenbin, Zhou Jian, Shi Yinghong, Fan Jia, and Tang Zheng
- Subjects
hepatocellular carcinoma ,complement ,immune infiltration ,prognosis ,drug response ,Biochemistry ,QD415-436 ,Genetics ,QH426-470 - Abstract
The complement cascade plays a “complementing” role in human immunity. However, the potential roles of complement system in impacting molecular and clinical features of hepatocellular carcinoma (HCC) remain unclear. In this study, eleven public datasets are analyzed to compare the complement status between normal and cancerous samples based on 18 classical complement-associated genes. The complement scores are constructed to quantify complement signatures of individual tumors. HCC patients in the The Cancer Genome Atlas (TCGA) cohort are focused to perform systematical analyses between complement status and immune infiltration, miRNA expression, DNA methylation, clinicopathological features, and drug response. The results show that the complement scores in normal tissues are dramatically higher than those of tumor tissues. Tumor samples in the TCGA cohort are classified into complement score-low and score-high groups. Pathway analysis reveals that tumor-promoting pathways are typically inhibited in complement score-high group. This study also shows that tumor-killing immune cells, such as CD8 + T cells and natural killer cells are abundant and tumor-suppressing miRNAs are upregulated in complement score-high samples. In addition, we identify that complement scores are negatively correlated with certain clinical features, including pathological grade, clinical-stage, and portal vein invasion. Moreover, various molecular features together with complement scores are found to be correlated with response to anti-cancer drugs. This study provides a comprehensive and multidimensional analysis conducive to understanding the role of complement in cancer.
- Published
- 2022
- Full Text
- View/download PDF
5. Multi-omics characterization reveals the pathogenesis of liver focal nodular hyperplasia
- Author
-
Liu, Yuming, Zhang, Jinmai, Wang, Zhuo, Ma, Jiaqiang, Wang, Ke, Rao, Dongning, Zhang, Mao, Lin, Youpei, Wu, Yingcheng, Yang, Zijian, Dong, Liangqing, Ding, Zhenbin, Zhang, Xiaoming, Fan, Jia, Shi, Yongyong, and Gao, Qiang
- Published
- 2022
- Full Text
- View/download PDF
6. Whole‐exome sequencing‐based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma.
- Author
-
Bu, Yichao, Huang, Run, Gao, Jun, Qu, Weifeng, Fu, Xiutao, Liu, Weiren, Ding, Zhenbin, Zhou, Jian, Fan, Jia, Wang, Xin, Chen, Diyu, and Tang, Zheng
- Subjects
HEPATOCELLULAR carcinoma ,ADENOMA ,BENIGN tumors ,MATRIX decomposition ,NONNEGATIVE matrices - Abstract
Hepatocellular adenoma (HCA) represents a rare benign hepatic neoplasm with potential for malignant transformation into hepatocellular carcinoma (HCC), yet the underlying mechanism remains elusive. In this study, we investigated the genomic landscape of this process to identify therapeutic strategies for blocking malignant transformation. Using micro‐detection techniques, we obtained specimens of adenoma, cancerous neoplasm and adjacent normal liver from three patients undergoing hepatic resection surgery. Whole‐exome sequencing (WES) was performed, and genomic interactions between HCA and HCC components within the same tumour were evaluated using somatic variant calling, copy number variation (CNV) analysis, clonality evaluation and mutational signature analysis. Our results revealed genomic heterogeneity among patient cases, yet within each sample, HCA and HCC tissues exhibited a similar mutational landscape, suggesting a high degree of homology. Using nonnegative matrix factorization and phylogenetic trees, we identified shared and distinct mutational characteristics and uncovering necessary pathways associated with HCA–HCC malignant transformation. Remarkably, we found that HCA and HCC shared a common monoclonal origin while displaying significant genetic diversity within HCA–HCC tumours, indicating fundamental genetic connections or evolutionary pathways between the two. Moreover, elevated immune therapy‐related markers in these patients suggested heightened sensitivity to immune therapy, providing novel avenues for the treatment of hepatic malignancies. This study sheds light on the genetic mechanisms underlying HCA–HCC progression, offering potential targets for therapeutic intervention and highlighting the promise of immune‐based therapies in managing hepatic malignancies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. A single-arm, multi-center phase II study of tislelizumab combined with lenvatinib and GEMOX as conversion therapy in potentially resectable locally advanced biliary tract cancer (ZSAB-TransGOLP): A primary analysis.
- Author
-
Fan, Jia, Zhou, Jian, Shi, Guoming, Huang, Xiaoyong, Gao, Qiang, Li, Xiaowu, Ji, Yuan, Liang, Fei, Chen, Yi, Lu, Pinxiang, Qiu, Shuangjian, Ren, Ning, Shen, Yinghao, Xu, Yongfeng, Ding, Zhenbin, Zhu, Xiaodong, Sun, Huichuan, Shi, Yinghong, Wang, Xiaoying, and Yi, Yong
- Published
- 2024
- Full Text
- View/download PDF
8. ZSAB-TOP: A phase 2 trial of tislelizumab (TIS) and ociperlimab (OCI) combined with gemcitabine and cisplatin (GemCis) as the first-line treatment for advanced biliary tract cancer (BTC).
- Author
-
Fan, Jia, Zhou, Jian, Shi, Guoming, Huang, Xiaoyong, Ma, Liang, Wang, Jun-Ye, Gao, Qiang, Qiu, Shuangjian, Sun, Huichuan, Shi, Yinghong, Huang, Xiao-Wu, Wang, Xiaoying, Yi, Yong, Zhu, Xiaodong, Huang, Cheng, Ding, Zhenbin, Chen, Yi, He, Yi-Feng, Shen, Yinghao, and Sun, Qiman
- Published
- 2024
- Full Text
- View/download PDF
9. Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma.
- Author
-
Pan, Jiaomeng, Zhang, Mao, Dong, Liangqing, Ji, Shuyi, Zhang, Juan, Zhang, Shu, Lin, Youpei, Wang, Xiaoying, Ding, Zhenbin, Qiu, Shuangjian, Gao, Daming, Zhou, Jian, Fan, Jia, and Gao, Qiang
- Subjects
HEPATOCELLULAR carcinoma ,MEDICAL screening ,CRISPRS ,MEMBRANE proteins ,CELL lines ,FLUOROSCOPY - Abstract
Drug resistance has greatly limited the clinical efficacy of lenvatinib in hepatocellular carcinoma (HCC). However, the underlying molecular mechanisms of lenvatinib resistance remain largely undetermined. Further in-depth exploration of mechanisms underlying lenvatinib resistance is still required for the majority of HCC patients. In this study, an integrated unbiased whole-genome CRISPR-Cas9 screen with database analysis indicated LAPTM5 (lysosomal protein transmembrane 5) as the critical contributor to lenvatinib resistance in HCC. We revealed that LAPTM5 could promote intrinsic macroautophagic/autophagic flux by facilitating autolysosome formation to drive lenvatinib resistance. The upregulation of LAPTM5 in HCC was induced by both DNA hypomethylation and driver mutations like TP53. Inhibition of autolysosome formation by either hydroxychloroquine (HCQ) or LAPTM5 abrogation worked synergistically with lenvatinib to inhibit tumor growth. In HCC cell lines, patient-derived primary cell lines and organoids, as well as human HCC xenografts and immunocompetent mouse HCC model, the close association between LAPTM5 and sensitivity to lenvatinib was consistently verified. Importantly, in clinical HCC samples, where lenvatinib was used as the first line or adjuvant therapy, LAPTM5 expression negatively correlated with lenvatinib sensitivity, implying it as a biomarker to predict patient response to lenvatinib. In conclusion, the combinational therapy targeting autophagy represented a promising strategy to overcome lenvatinib resistance in HCC, and LAPTM5 expression could provide potential guidance for clinical interference. cld-CASP3: cleaved caspase 3; cld-PARP: cleaved PARP; DTP: drug tolerant persister; GO: Gene Ontology; GTEx: The Genotype-Tissue Expression; HCC: hepatocellular carcinoma; HCQ: hydroxychloroquine; IC50: half maximal inhibitory concentration value; KEGG: Kyoto Encyclopedia of Genes and Genomes; LAPTM5: lysosomal protein transmembrane 5; NT: non-targeting; PDC: patient-derived primary cell lines; PDO: patient-derived primary organoid; TCGA: The Cancer Genome Atlas. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial–mesenchymal transition and mitochondrial function maintenance.
- Author
-
Chen, Jiafeng, Gao, Zheng, Li, Xiaogang, Shi, Yinghong, Tang, Zheng, Liu, Weiren, Zhang, Xin, Huang, Ao, Luo, Xuanming, Gao, Qiang, Ding, Guangyu, Song, Kang, Zhou, Jian, Fan, Jia, Fu, Xiutao, and Ding, Zhenbin
- Subjects
EPITHELIAL-mesenchymal transition ,CANCER invasiveness ,CHOLANGIOCARCINOMA ,WESTERN immunoblotting ,MITOCHONDRIA ,LYMPHATIC metastasis ,PANCREATIC intraepithelial neoplasia - Abstract
Background: SQSTM1/p62 is a selective autophagy receptor that regulates multiple signaling pathways participating in the initiation and progression of tumors. Metastasis is still the main cause for intrahepatic cholangiocarcinoma (ICC)‐associated mortality. Hence, this study aimed to explore the mechanism of p62 promoting the progression of ICC. Methods: Western blotting and immunohistochemical analyses were conducted to detect the expression level of protein p62 in ICC tissues and its correlation with prognosis. Subsequently, the loss‐of‐function experiments in vitro and in vivo were performed to define the role of p62 in ICC cell proliferation, invasion, and metastasis. Then, the effect of p62 knockdown on mitochondrial function and mitophagy was evaluated by measuring the oxygen consumption rate, and using immunofluorescence and western blotting analyses. Results: The expression of p62 was significantly upregulated in ICC specimens compared with normal tissues. We further illustrated that p62 expression positively correlated with lymph node metastasis and poor prognosis. The loss‐of‐function assays revealed that p62 not only promoted ICC cell proliferation, migration, and invasive capacities in vitro, but also induced lung metastasis in the xenograft mouse model. Mechanistically, high expression of p62‐induced epithelial–mesenchymal transition (EMT) with the upregulation of Snail, vimentin, N‐cadherin, and downregulation of E‐cadherin. Moreover, the autophagy‐dependent function of p62 might play a vital role in maintaining the mitochondrial function of ICC by mitophagy which might further promote EMT. Conclusion: These data provided new evidence for the mechanism by which abundant p62 expression promoted ICC progression, suggesting a promising therapeutic target for antimetastatic strategies in patients with ICC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.
- Author
-
Fang, Yuan, Liu, Weiren, Tang, Zheng, Ji, Xiang, Zhou, Yufu, Song, Shushu, Tian, Mengxin, Tao, Chenyang, Huang, Run, Zhu, Guiqi, Jiang, Xifei, Gao, Jun, Qu, Weifeng, Wang, Han, Zhou, Peiyun, Wu, Xiaoling, Jin, Lei, Sun, Haixiang, Ding, Zhenbin, and Peng, Yuanfei
- Published
- 2023
- Full Text
- View/download PDF
12. Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: ISICC‐applied prediction model.
- Author
-
Tian, Mengxin, Liu, Weiren, Tao, Chenyang, Tang, Zheng, Zhou, Yufu, Song, Shushu, Jin, Lei, Wang, Han, Jiang, Xifei, Zhou, Peiyun, Fang, Yuan, Qu, Weifeng, Ding, Zhenbin, Peng, Yuanfei, Fu, Xiutao, Qiu, Shuangjian, Zhou, Jian, Fan, Jia, and Shi, Yinghong
- Abstract
Intrahepatic cholangiocarcinoma (ICC) remains a highly heterogeneous disease with poor prognosis. Tumor‐infiltrating lymphocytes were predictive in various cancers, but their prognostic value in ICC is less clear. A total of 168 ICC patients who had received liver resection were enrolled and assigned to the derivation cohort. Sixteen immune markers in tumor and peritumor regions were examined by immunohistochemistry. A least absolute shrinkage and selection operator model was used to identify prognostic markers and to establish an immune signature for ICC (ISICC). An ISICC‐applied prediction model was built and validated in another independent dataset. Five immune features, including CD3peritumor (P), CD57P, CD45RAP, CD66bintratumoral (T) and PD‐L1P, were identified and integrated into an individualized ISICC for each patient. Seven prognostic predictors, including total bilirubin, tumor numbers, CEA, CA19‐9, GGT, HBsAg and ISICC, were integrated into the final model. The C‐index of the ISICC‐applied prediction model was 0.719 (95% CI, 0.660‐0.777) in the derivation cohort and 0.667 (95% CI, 0.581‐0.732) in the validation cohort. Compared with the conventional staging systems, the new model presented better homogeneity and a lower Akaike information criteria value in ICC. The ISICC‐applied prediction model may provide a better prediction performance for the overall survival of patients with resectable ICC in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. miR-20a-5p/TGFBR2 Axis Affects Pro-inflammatory Macrophages and Aggravates Liver Fibrosis.
- Author
-
Fu, Xiutao, Qie, Jingbo, Fu, Qingchun, Chen, Jiafeng, Jin, Yinpeng, and Ding, Zhenbin
- Subjects
FIBROSIS ,LIVER ,LIVER cells ,MACROPHAGE activation ,MACROPHAGES - Abstract
Combined inhibition of programmed death-ligand 1 (PD-L1) and transforming growth factor-β (TGF-β) displayed additive anti-tumor response in a subgroup of cancer patients, highlighting the importance of understanding the multifaceted roles of TGF-β in immunity and fibrosis. In the present research, we show that TGF-β signaling pathway, controlled by miR-20a-5p and transforming growth factor-β receptor 2 (TGFBR2), alters the inflammation and fibrosis processes in liver. We performed integrated analysis of differently expressed miRNA (DEM) associated with liver fibrosis and screened miR-20a-5p out as a key regulator in inflammation-driven liver fibrosis. We subsequently conducted Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the genes targeted by miR-20a-5p. And the result showed that 12 target genes were significantly enriched in TGF-β signaling pathway. Further study showed that miR-20a-5p was down-regulated and involved in inflammation during liver fibrosis in human and mouse samples, indicating that miR-20a-5p and inflammation are functionally linked during liver fibrosis progression. To uncover the underlying pro-inflammatory mechanism of miR-20a-5p in liver fibrosis, we selected and verified TGFBR2, which is a key functional receptor in TGF-β signaling pathway, as a direct target gene of miR-20a-5p. The downregulation of miR-20a-5p in liver fibrosis resulted in TGFBR2-activated TGF-β signaling pathway, followed by the activation of macrophage and extracellular matrix (ECM) production by hepatic stellate cell (HSC). Our results identify the miR-20a-5p/TGFBR2 axis as a key regulator of TGF-β signaling, and highlight the critical role of miR-20a-5p in the development of liver fibrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. Groundwater Quality and Potential Human Health Risk Assessment for Drinking and Irrigation Purposes: A Case Study in the Semiarid Region of North China.
- Author
-
Chen, Feifei, Yao, Leihua, Mei, Gang, Shang, Yinsheng, Xiong, Fansheng, Ding, Zhenbin, and Missimer, Thomas
- Subjects
GROUNDWATER quality ,HEALTH risk assessment ,ARID regions ,DRINKING water quality ,IRRIGATION ,DRINKING water - Abstract
Groundwater is a valuable water source for drinking and irrigation purposes in semiarid regions. Groundwater pollution may affect human health if it is not pretreated and provided for human use. This study investigated the hydrochemical characteristics driving groundwater quality for drinking and irrigation purposes and potential human health risks in the Xinzhou Basin, Shanxi Province, North China. More specifically, we first investigated hydrochemical characteristics using a descriptive statistical analysis method. We then classified the hydrochemical types and analyzed the evolution mechanisms of groundwater using Piper and Gibbs diagrams. Finally, we appraised the groundwater quality for drinking and irrigation purposes using the entropy water quality index (EWQI). We assessed the associated human health risks for different age and sex groups through drinking intake and dermal contact pathways. Overall, we found that (1) Ca-HCO
3 and Ca·Mg-HCO3 were the dominant hydrochemical types and were mainly governed by rock weathering and water–rock interactions. (2) Based on the EWQI classifications, 67.74% of the groundwater samples were classified as medium quality and acceptable for drinking purpose. According to the values of sodium adsorption ratio (SAR), residual sodium carbonate (RSC) and soluble sodium percentage (%Na), 90.32% of the samples were suitable for irrigation, while the remaining samples were unfit for irrigation because of the high salinity in the groundwater. (3) Some contaminants in the groundwater, such as NO3 − , NO2 − and F− , exceeded the standard limits and may cause potential risks to human health. Our work presented in this paper could establish reasonable management strategies for sustainable groundwater quality protection to protect public health. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
15. Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6 + CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma.
- Author
-
Li X, Gao Z, Chen J, Feng S, Luo X, Shi Y, Tang Z, Liu W, Zhang X, Huang A, Gao Q, Ke A, Zhou J, Fan J, Fu X, and Ding Z
- Abstract
Background: Various immune cell types in the tumor microenvironment (TME) of hepatocellular carcinoma (HCC) have been identified as important parameters associated with prognosis and responsiveness to immunotherapy. However, how various factors influence immune cell infiltration remains incompletely understood. Hence, we investigated the single cell multi-omics landscape of immune infiltration in HCC, particularly key gene and cell subsets that influence immune infiltration, thus potentially linking the immunotherapy response and immune cell infiltration., Methods: We grouped patients with HCC according to immune cell infiltration scores calculated by single sample gene set enrichment analysis (ssGSEA). Differential expression analysis, functional enrichment, clinical trait association, gene mutation analysis, tumor immune dysfunction and exclusion (TIDE) and prognostic model construction were used to investigate the immune infiltration landscape through multi-omics. Stepwise regression was further used to identify key genes regulating immune infiltration. Single cell analysis was performed to explore expression patterns of candidate genes and investigate associated cellular populations. Correlation analysis, ROC analysis, Immunotherapy cohorts were used to explore and confirm the role of key gene and cellular population in predicting immune infiltration state and immunotherapy response. Immunohistochemistry and multiplexed fluorescence staining were used to further validated our results., Results: Patients with HCC were clustered into high and low immune infiltration groups. Mutations of CTNNB1 and TTN were significantly associated with immune infiltration and altered enrichment of cell populations in the TME. TIDE analysis demonstrated that T cell dysfunction and the T cell exclusion score were elevated in the high and low infiltration groups, respectively. Six risk genes and five risk immune cell types were identified and used to construct risk scores and a nomogram model. CXCR6 and LTA, identified by stepwise regression, were highly associated with immune infiltration. Single cell analysis revealed that LTA was expressed primarily in tumor infiltrating T lymphocytes and partial B lymphocytes, whereas CXCR6 was enriched predominantly in T and NK cells. Notably, CXCR6
+ CD8 T cells were characterized as tumor enriched cells that may be potential predictors of high immune infiltration and the immune-checkpoint blockade response, and may serve as therapeutic targets., Conclusion: We constructed a comprehensive single cell and multi-omics landscape of immune infiltration in HCC, and delineated key genes and cellular populations regulating immune infiltration and immunotherapy response, thus providing insights into the mechanisms of immune infiltration and future therapeutic control., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Li, Gao, Chen, Feng, Luo, Shi, Tang, Liu, Zhang, Huang, Gao, Ke, Zhou, Fan, Fu and Ding.)- Published
- 2023
- Full Text
- View/download PDF
16. Emergent hybrid-dual-graft liver transplantation: a life-saving strategy for a patient with inadequate living donor graft during the COVID-19 pandemic.
- Author
-
Xiao Y, Huang X, Shi Y, Wang Z, Wang X, He Y, Wang T, Sun J, Song K, Ding Z, Shen Y, Peng Y, Shen Z, Yu L, Zhu K, Li H, Zhou D, Miao C, Ji Y, Yang L, Hou Y, Qu X, Fan J, and Zhou J
- Abstract
Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-22-335/coif). The authors have no conflicts of interest to declare.
- Published
- 2022
- Full Text
- View/download PDF
17. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation.
- Author
-
Guo R, Jia X, Ding Z, Wang G, Jiang M, Li B, Chen S, Xia B, Zhang Q, Liu J, Zheng R, Gao Z, and Xie X
- Subjects
- Animals, Apoptosis, Fibrosis, Hepatocytes metabolism, Humans, Liver Cirrhosis metabolism, Mice, Necrosis metabolism, Protein Kinases genetics, Protein Kinases metabolism, Hepatic Stellate Cells metabolism, Necroptosis
- Abstract
Background: Liver fibrosis affects millions of people worldwide without an effective treatment. Although multiple cell types in the liver contribute to the fibrogenic process, hepatocyte death is considered to be the trigger. Multiple forms of cell death, including necrosis, apoptosis, and necroptosis, have been reported to co-exist in liver diseases. Mixed lineage kinase domain-like protein ( MLKL ) is the terminal effector in necroptosis pathway. Although necroptosis has been reported to play an important role in a number of liver diseases, the function of MLKL in liver fibrosis has yet to be unraveled. Methods and Results: Here we report that MLKL level is positively correlated with a number of fibrotic markers in liver samples from both patients with liver fibrosis and animal models. Mlkl deletion in mice significantly reduces clinical symptoms of CCl
4 - and bile duct ligation (BDL) -induced liver injury and fibrosis. Further studies indicate that Mlkl-/- blocks liver fibrosis by reducing hepatocyte necroptosis and hepatic stellate cell (HSC) activation. AAV8-mediated specific knockdown of Mlkl in hepatocytes remarkably alleviates CCl4 -induced liver fibrosis in both preventative and therapeutic ways. Conclusion: Our results show that MLKL-mediated signaling plays an important role in liver damage and fibrosis, and targeting MLKL might be an effective way to treat liver fibrosis., Competing Interests: Competing Interests: The authors have declared that no competing interest exists., (© The author(s).)- Published
- 2022
- Full Text
- View/download PDF
18. LINC00355 triggers malignant progression of hepatocellular carcinoma via the sponge effect on miR-217-5p with the involvement of the Wnt/β-catenin signaling.
- Author
-
Luo X, ABudureyimu M, Yang G, Yan Z, Fu X, Lu P, Zhang D, Zhang S, and Ding Z
- Subjects
- Disease Progression, Humans, Tumor Cells, Cultured, Carcinoma, Hepatocellular pathology, Liver Neoplasms pathology, MicroRNAs physiology, RNA, Long Noncoding physiology, Wnt Signaling Pathway physiology
- Abstract
Purpose: To uncover the biological role of LINC00355 in regulating the proliferative and apoptotic potentials in hepatocellular carcinoma (HCC), and the underlying mechanism., Methods: LINC00355 levels in HCC tissues and cell lines were detected by quantitative real-time polymerase chain reaction (qRT-PCR). After knockdown of LINC00355 or miR-217-5p in Hub7 and Hep3B cells, proliferative and apoptotic potentials were assessed by cell counting kit-8 (CCK-8), colony formation assay and flow cytometry. The interaction between LINC00355 and miR-217-5p was determined by dual-luciferase reporter assay and Pearson correlation test. Western blot analysis was conducted to illustrate the regulatory effects of LINC00355 and miR-217-5p on the Wnt/β-catenin signaling., Results: LINC00355 was upregulated in HCC tissues and cell lines. Knockdown of LINC00355 reduced viability in Hub7 and Hep3B cells, which was much pronounced on days 3 and 4. Clonality was attenuated by transfection of shLINC00355 as well. In addition, apoptosis rate increased by knockdown of LINC00355 in HCC cells. Protein levels of β-catenin, GSK3β, c-myc and cyclin D1 were downregulated in Hub7 and Hep3B cells transfected with shLINC00355. MiR-217-5p was the target gene binding LINC00355. It displayed exactly opposite regulations on HCC cell phenotypes and protein levels of vital genes in the Wnt/β-catenin signaling to those of LINC00355., Conclusions: LINC00355 is upregulated in HCC specimens, LINC00355 triggers proliferative rate and inhibits apoptosis in HCC cells by negatively regulating miR-217-5p and activating the Wnt/β-catenin signaling.
- Published
- 2021
19. Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS ICC -applied prediction model.
- Author
-
Tian M, Liu W, Tao C, Tang Z, Zhou Y, Song S, Jin L, Wang H, Jiang X, Zhou P, Fang Y, Qu W, Ding Z, Peng Y, Fu X, Qiu S, Zhou J, Fan J, and Shi Y
- Subjects
- Aged, Cholangiocarcinoma epidemiology, Cholangiocarcinoma pathology, Cohort Studies, Disease-Free Survival, Female, Gene Expression Regulation, Neoplastic genetics, Hepatectomy, Humans, Liver Neoplasms epidemiology, Liver Neoplasms pathology, Male, Middle Aged, Neoplasm Proteins genetics, Cholangiocarcinoma surgery, Liver Neoplasms surgery, Lymphocytes, Tumor-Infiltrating pathology, Prognosis
- Abstract
Intrahepatic cholangiocarcinoma (ICC) remains a highly heterogeneous disease with poor prognosis. Tumor-infiltrating lymphocytes were predictive in various cancers, but their prognostic value in ICC is less clear. A total of 168 ICC patients who had received liver resection were enrolled and assigned to the derivation cohort. Sixteen immune markers in tumor and peritumor regions were examined by immunohistochemistry. A least absolute shrinkage and selection operator model was used to identify prognostic markers and to establish an immune signature for ICC (IS
ICC ). An ISICC -applied prediction model was built and validated in another independent dataset. Five immune features, including CD3peritumor (P) , CD57P , CD45RAP , CD66bintratumoral (T) and PD-L1P , were identified and integrated into an individualized ISICC for each patient. Seven prognostic predictors, including total bilirubin, tumor numbers, CEA, CA19-9, GGT, HBsAg and ISICC , were integrated into the final model. The C-index of the ISICC -applied prediction model was 0.719 (95% CI, 0.660-0.777) in the derivation cohort and 0.667 (95% CI, 0.581-0.732) in the validation cohort. Compared with the conventional staging systems, the new model presented better homogeneity and a lower Akaike information criteria value in ICC. The ISICC -applied prediction model may provide a better prediction performance for the overall survival of patients with resectable ICC in clinical practice., (© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)- Published
- 2020
- Full Text
- View/download PDF
20. Coagulopathy associated with poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection.
- Author
-
Wang H, Liu W, Tian M, Tang Z, Jiang X, Zhou P, Ding Z, Peng Y, Dai Z, Qiu S, Zhou J, Fan J, and Shi Y
- Subjects
- Disease-Free Survival, Female, Follow-Up Studies, Humans, Male, Middle Aged, Multivariate Analysis, Postoperative Care, Prognosis, Survival Analysis, Bile Duct Neoplasms complications, Bile Duct Neoplasms surgery, Blood Coagulation Disorders complications, Cholangiocarcinoma complications, Cholangiocarcinoma surgery
- Abstract
As a rare type of liver cancer, intrahepatic cholangiocarcinoma (ICC) has become an increasingly important malignancy and continues to present significant therapeutic challenges. Since coagulopathy is associated with poor prognosis in hepatocellular carcinoma (HCC), and prognostic factors of ICC after curative resection were still not clear, we aim to analyze the characteristics of ICC patients with coagulopathy and its correlation to prognosis. From January 2000 to June 2011, 541 ICC patients, after curative resection, were enrolled in our study. Survival curves were depicted by the Kaplan-Meier method and analyzed by the log-rank test. The Cox proportional hazard regression was adopted for multivariate survival analysis. Student's t test was performed to analyze the difference between the coagulopathy group and the normal group. The correlation between coagulation parameters and prognosis was also evaluated. The incidence rate of at least one coagulation parameter abnormality was 22.6% (122/541) while PT was the most common factor (8.87%, 48/541). The one-year survival rate of patients with coagulopathy was significantly lower than that of patients with normal coagulation (p < 0.01). In a univariate analysis, patients with prolonged PT was associated with shortened DFS (p < 0.05). Meanwhile, PT was negatively correlated with pre-albumin level. TNM stage, CA19-9, GGT, and pre-albumin level were independent prognostic factors of DFS in the multivariate analysis. In conclusion, the incidence rate of coagulopathy of ICC patients is lower than HCC patients. Prolonged PT, advanced TNM stage, low pre-albumin level, and high CA19-9 and GGT level were correlated with high recurrence rate and poor prognosis.
- Published
- 2017
- Full Text
- View/download PDF
21. The nanomechanical signature of liver cancer tissues and its molecular origin.
- Author
-
Tian M, Li Y, Liu W, Jin L, Jiang X, Wang X, Ding Z, Peng Y, Zhou J, Fan J, Cao Y, Wang W, and Shi Y
- Subjects
- Adaptor Proteins, Signal Transducing antagonists & inhibitors, Adaptor Proteins, Signal Transducing genetics, Adaptor Proteins, Signal Transducing metabolism, Carcinoma, Hepatocellular metabolism, Carcinoma, Hepatocellular pathology, Cell Line, Tumor, Cell Movement, Cell Proliferation, Elastic Modulus, Formins, Humans, Liver pathology, Liver Cirrhosis metabolism, Liver Cirrhosis pathology, Liver Neoplasms metabolism, Microscopy, Atomic Force, Microscopy, Electron, Scanning, RNA Interference, RNA, Small Interfering metabolism, rho GTP-Binding Proteins metabolism, rhoC GTP-Binding Protein, Liver Neoplasms pathology, Nanotechnology
- Abstract
Patients with cirrhosis are at higher risk of developing hepatocellular carcinoma (HCC), the second most frequent cause of cancer-related deaths. Although HCC diagnosis based on conventional morphological characteristics serves as the "gold standard" in the clinic, there is a high demand for more convenient and effective diagnostic methods that employ new biophysical perspectives. Here, we show that the nanomechanical signature of liver tissue is directly correlated with the development of HCC. Using indentation-type atomic force microscopy (IT-AFM), we demonstrate that the lowest elasticity peak (LEP) in the Young's modulus distribution of surgically removed liver cancer tissues can serve as a mechanical fingerprint to evaluate the malignancy of liver cancer. Cirrhotic tissues shared the same LEP as normal tissues. However, a noticeable downward shift in the LEP was detected when the cirrhotic tissues progressed to a malignant state, making the tumor tissues more prone to microvascular invasion. Cell-level mechanistic studies revealed that the expression level of a Rho-family effector (mDia1) was consistent with the mechanical trend exhibited by the tissue. Our findings indicate that the mechanical profiles of liver cancer tissues directly varied with tumor progression, providing an additional platform for the future diagnosis of HCC.
- Published
- 2015
- Full Text
- View/download PDF
22. LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis.
- Author
-
Tian M, Liu W, Jin L, Jiang X, Yang L, Ding Z, Shen Y, Peng Y, Gao D, Li L, Zhou J, Qiu S, Dai Z, Fan J, and Shi Y
- Subjects
- Amino Acid Oxidoreductases genetics, Carcinoma, Hepatocellular genetics, Carcinoma, Hepatocellular mortality, Carcinoma, Hepatocellular pathology, Cell Line, Tumor, Female, Gene Expression Regulation, Neoplastic, Humans, Liver Neoplasms genetics, Liver Neoplasms mortality, Liver Neoplasms pathology, Male, Middle Aged, Neoplasm Recurrence, Local genetics, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local pathology, Prognosis, Protein-Lysine 6-Oxidase, RNA, Small Interfering, Survival Rate, Amino Acid Oxidoreductases metabolism, Carcinoma, Hepatocellular metabolism, Down-Regulation, Liver Neoplasms metabolism, Neoplasm Recurrence, Local metabolism
- Abstract
Lysyl oxidase like 4 (LOXL4), a member of the secreted copper-dependent amine oxidases that contribute to the assemble and maintenance of the extracellular matrix (ECM), was found to be up-regulated or down-regulated in different cancer types, suggesting its paradoxical roles in cancer. The specific role of LOXL4 in hepatocellular carcinoma (HCC), however, is still yet to be defined. Twenty-eight pairs of HCC specimens were used for LOXL4 mRNA expression analysis. The mRNA expression in HCC cell lines was examined, and HepG2 was selected for LOXL4 small interfering RNA (siRNA) interference to investigate the biological function of LOXL4, LOXL4 immunohistochemical staining was performed using a tissue microarray containing 298 HCC patients. The prognostic and diagnostic value of LOXL4 was evaluated using Cox regression and Kaplan-Meier analysis. LOXL4 mRNA or protein expression was significantly lower in HCC tissues than peritumoral tissues (LOXL4 mRNA expression, P = 0.018; LOXL4 protein expression, P < 0.001). Low LOXL4 expression was associated with lower overall survival (OS) rates and higher cumulative recurrence rates. Multivariate analysis indicated that LOXL4 was an independent prognostic indicator for OS and time to recurrence (TTR). Our results revealed that LOXL4 was down-regulated in HCC and correlated with aggressive tumors and a worse clinical outcome. LOXL4 may be a potential biomarker to identify the HCC patients with a higher risk of recurrence.
- Published
- 2015
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.